No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d1uj1B_, 1.0000, 0.00, 1.000, 302, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO)
2, d1uk4B_, 0.9964, 0.38, 1.000, 302, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) COMPLEXED WITH AN INHIBITOR
3, d2ducB_, 0.9927, 0.64, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE(3CLPRO)
4, d2qc2B_, 0.9912, 0.65, 0.993, 305, 302, CRYSTAL STRUCTURE OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) 3C-LIKE PROTEASE ASN214ALA MUTANT
5, d2amdB1, 0.9912, 0.67, 1.000, 302, 302, CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N9
6, d1wofB1, 0.9912, 0.66, 1.000, 302, 302, CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR N1
7, d2q6gB_, 0.9898, 0.73, 0.997, 302, 302, CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE H41A MUTANT IN COMPLEX WITH AN N-TERMINAL SUBSTRATE
8, d2z9jA_, 0.9896, 0.75, 1.000, 302, 302, COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH EPDTC
9, d2amqB_, 0.9890, 0.78, 1.000, 302, 302, CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N3
10, d2z9kB_, 0.9889, 0.79, 1.000, 306, 302, COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH JMF1600
11, d2gt7B_, 0.9886, 0.80, 1.000, 302, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PEPTIDASE AT PH 6.0 IN THE SPACE GROUP P21
12, d3m3sB_, 0.9884, 0.80, 0.997, 302, 302, CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE ASN214ALA MUTANT WITH AUTHORIZE N-TERMINUS
13, d3sndA_, 0.9881, 0.82, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC- ESTLQ-H (COCRYSTALLIZATION)
14, d3ea8A_, 0.9878, 0.81, 0.990, 306, 302, CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE TRIPLE MUTANT STI/A IN SPACE GROUP C2
15, d2h2zA_, 0.9877, 0.83, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE WITH AUTHENTIC N AND C-TERMINI
16, d2op9A2, 0.9874, 0.68, 1.000, 301, 301, SUBSTRATE SPECIFICITY PROFILING AND IDENTIFICATION OF A NEW CLASS OF INHIBITOR FOR THE MAJOR PROTEASE OF THE SARS CORONAVIRUS
17, d4wy3A_, 0.9873, 0.83, 0.997, 306, 302, STRUCTURE OF SARS-3CL PROTEASE COMPLEX WITH A PHENYLBENZOYL (RS)-N- DECALIN TYPE INHIBITOR
18, d4twxA_, 0.9873, 0.83, 0.997, 306, 302,  
19, d2z3dA_, 0.9872, 0.84, 1.000, 306, 302, A MECHANISTIC VIEW OF ENZYME INHIBITION AND PEPTIDE HYDROLYSIS IN THE ACTIVE SITE OF THE SARS-COV 3C-LIKE PEPTIDASE
20, d2a5kA_, 0.9872, 0.81, 1.000, 304, 302, CRYSTAL STRUCTURES OF SARS CORONAVIRUS MAIN PEPTIDASE INHIBITED BY AN AZA-PEPTIDE EPOXIDE IN SPACE GROUP P212121
21, d3sneA_, 0.9871, 0.83, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC- ESTLQ-H (SOAKING)
22, d2gz9A_, 0.9871, 0.84, 1.000, 306, 302, STRUCTURE-BASED DRUG DESIGN AND STRUCTURAL BIOLOGY STUDY OF NOVEL NONPEPTIDE INHIBITORS OF SARS-COV MAIN PROTEASE
23, d3snbA_, 0.9870, 0.84, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC- DSFDQ-H (SOAKING)
24, d3aw1A_, 0.9870, 0.70, 0.997, 301, 301, STRUCTURE OF SARS 3CL PROTEASE AUTO-PROTEOLYSIS RESISTANT MUTANT IN THE ABSENT OF INHIBITOR
25, d2hobA_, 0.9870, 0.84, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE WITH AUTHENTIC N AND C- TERMINI IN COMPLEX WITH A MICHAEL ACCEPTOR N3
26, d2gz8A_, 0.9870, 0.84, 1.000, 306, 302, STRUCTURE-BASED DRUG DESIGN AND STRUCTURAL BIOLOGY STUDY OF NOVEL NONPEPTIDE INHIBITORS OF SARS-COV MAIN PROTEASE
27, d4twyA_, 0.9868, 0.84, 0.997, 306, 302, STRUCTURE OF SARS-3CL PROTEASE COMPLEX WITH A PHENYLBENZOYL (SR)-N- DECALIN TYPE INHIBITOR
28, d3eajB_, 0.9868, 0.83, 0.987, 302, 302, CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE QUADRUPLE MUTANT STIF/A WITH TWO MOLECULES IN ONE ASYMMETRIC UNIT
29, d5c5nA_, 0.9866, 0.85, 0.997, 306, 302, STRUCTURE OF SARS-3CL PROTEASE COMPLEX WITH A PHENYL-BETA-ALANYL (R S)-N-DECALIN TYPE INHIBITOR
30, d2z9lB_, 0.9866, 0.71, 1.000, 301, 301, COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH JMF1586
31, d2a5aA_, 0.9866, 0.85, 1.000, 306, 302, CRYSTAL STRUCTURE OF UNBOUND SARS CORONAVIRUS MAIN PEPTIDASE IN THE SPACE GROUP C2
32, d3tiuA_, 0.9864, 0.86, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHABETA-UNSATURATED ETHYL ESTER INHIBITOR SG82
33, d3sn8A_, 0.9864, 0.85, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH CM- FF-H (SOAKING)
34, d3m3vB1, 0.9864, 0.80, 0.990, 303, 302, SARS-COV MAIN PROTEASE TRIPLE MUTANT STI/A WITH TWO N-TERMINAL ADDITIONAL RESIDUE (GLY-SER)
35, d2z3cA_, 0.9864, 0.85, 1.000, 306, 302, A MECHANISTIC VIEW OF ENZYME INHIBITION AND PEPTIDE HYDROLYSIS IN THE ACTIVE SITE OF THE SARS-COV 3C-LIKE PEPTIDASE
36, d3aw0A_, 0.9863, 0.86, 0.997, 306, 302, STRUCTURE OF SARS 3CL PROTEASE WITH PEPTIDIC ALDEHYDE INHIBITOR
37, d2gx4A_, 0.9861, 0.87, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS 3CL PROTEASE INHIBITOR COMPLEX
38, d2zu5A_, 0.9860, 0.87, 1.000, 306, 302, COMPLEX STRUCTURE OF SARS-COV 3CL PROTEASE WITH TG-0205486
39, d2gz7A_, 0.9860, 0.86, 1.000, 306, 302, STRUCTURE-BASED DRUG DESIGN AND STRUCTURAL BIOLOGY STUDY OF NOVEL NONPEPTIDE INHIBITORS OF SARS-COV MAIN PROTEASE
40, d2cggB_, 0.9860, 0.63, 1.000, 300, 300,  
41, d3sznA_, 0.9859, 0.87, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHA BETA-UNSATURATED ETHYL ESTER SG75
42, d2z94A_, 0.9859, 0.87, 1.000, 306, 302, COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH TDT
43, d2vj1B_, 0.9859, 0.64, 1.000, 300, 300, A STRUCTURAL VIEW OF THE INACTIVATION OF THE SARS- CORONAVIRUS MAIN PROTEINASE BY BENZOTRIAZOLE ESTERS
44, d2d2dB_, 0.9859, 0.81, 1.000, 302, 302, CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR I2
45, d1wnqB_, 0.9859, 0.81, 1.000, 302, 302,  
46, d2zu4A_, 0.9858, 0.87, 1.000, 306, 302, COMPLEX STRUCTURE OF SARS-COV 3CL PROTEASE WITH TG-0204998
47, d2z3eA_, 0.9858, 0.87, 1.000, 306, 302, A MECHANISTIC VIEW OF ENZYME INHIBITION AND PEPTIDE HYDROLYSIS IN THE ACTIVE SITE OF THE SARS-COV 3C-LIKE PEPTIDASE
48, d3titA_, 0.9856, 0.88, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHA BETA-UNSATURATED ETHYL ESTER SG81
49, d2z9gA_, 0.9856, 0.88, 1.000, 306, 302, COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH PMA
50, d4mdsA1, 0.9854, 0.84, 1.000, 302, 302, DISCOVERY OF N-(BENZO[123]TRIAZOL-1-YL)-N-(BENZYL)ACETAMIDO)PHENYL) CARBOXAMIDES AS SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS- COV) 3CLPRO INHIBITORS: IDENTIFICATION OF ML300 AND NON-COVALENT NANOMOLAR INHIBITORS WITH AN INDUCED-FIT BINDING
51, d3v3mA_, 0.9853, 0.88, 1.000, 306, 302, SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-COV) 3CL PROTEASE IN COMPLEX WITH N-[(1R)-2-(TERT-BUTYLAMINO)-2-OXO-1-(PYRIDIN-3-YL) ETHYL]-N-(4-TERT-BUTYLPHENYL)FURAN-2-CARBOXAMIDE INHIBITOR.
52, d3sncA_, 0.9853, 0.88, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC- NSTSQ-H (SOAKING)
53, d3ea7A_, 0.9852, 0.85, 0.990, 305, 302, CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE TRIPLE MUTANT STI/A IN SPACE GROUP P21
54, d3tnsA_, 0.9850, 0.89, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHA BETA-UNSATURATED ETHYL ESTER INHIBITOR SG83
55, d2v6nA_, 0.9850, 0.89, 1.000, 306, 302, CRYSTAL STRUCTURES OF THE SARS-CORONAVIRUS MAIN PROTEINASE INACTIVATED BY BENZOTRIAZOLE COMPOUNDS
56, d2a5iA_, 0.9848, 0.89, 1.000, 306, 302, CRYSTAL STRUCTURES OF SARS CORONAVIRUS MAIN PEPTIDASE INHIBITED BY AN AZA-PEPTIDE EPOXIDE IN THE SPACE GROUP C2
57, d3ea7B_, 0.9847, 0.75, 0.990, 301, 301, CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE TRIPLE MUTANT STI/A IN SPACE GROUP P21
58, d3eajA_, 0.9846, 0.92, 0.987, 302, 302, CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE QUADRUPLE MUTANT STIF/A WITH TWO MOLECULES IN ONE ASYMMETRIC UNIT
59, d3tntA_, 0.9843, 0.92, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHA BETA-UNSATURATED ETHYL ESTER INHIBITOR SG85
60, d2bw6A_, 0.9841, 0.80, 1.000, 301, 301,  
61, d3e91A_, 0.9833, 0.89, 0.990, 305, 302, CRYSTAL STRUCTURE OF SARS-COV MPRO MUTANT IN P21 AT PH6.9
62, d3vb3A_, 0.9831, 0.80, 1.000, 301, 301, CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE IN APO FORM
63, d3snaA_, 0.9828, 0.82, 1.000, 301, 301, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC- NSFSQ-H (SOAKING)
64, d3ea9A_, 0.9828, 0.81, 0.987, 301, 301, CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE QUADRUPLE MUTANT STIF/A WITH ONE MOLECULE IN ONE ASYMMETRIC UNIT
65, d2z9jB_, 0.9824, 0.92, 1.000, 304, 302, COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH EPDTC
66, d3vb3B_, 0.9821, 0.94, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE IN APO FORM
67, d3e91B_, 0.9820, 0.73, 0.990, 300, 300, CRYSTAL STRUCTURE OF SARS-COV MPRO MUTANT IN P21 AT PH6.9
68, d3aw1B_, 0.9819, 0.75, 0.997, 300, 300, STRUCTURE OF SARS 3CL PROTEASE AUTO-PROTEOLYSIS RESISTANT MUTANT IN THE ABSENT OF INHIBITOR
69, d2z9kA_, 0.9819, 0.93, 1.000, 305, 302, COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH JMF1600
70, d4twwA_, 0.9818, 0.96, 0.997, 306, 302, STRUCTURE OF SARS-3CL PROTEASE COMPLEX WITH A BROMOBENZOYL (SR)-N- DECALIN TYPE INHIBITOR
71, d2c3sA_, 0.9818, 1.01, 1.000, 301, 301, STRUCTURE OF SARS COV MAIN PROTEINASE AT 1.9 A (PH6.5)
72, d3m3sA_, 0.9816, 0.94, 0.997, 306, 302, CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE ASN214ALA MUTANT WITH AUTHORIZE N-TERMINUS
73, d2qiqA2, 0.9812, 0.78, 1.000, 300, 300, STRUCTURE-BASED DESIGN AND SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC SARS-3CLPRO INHIBITORS
74, d2a5kB_, 0.9808, 0.80, 1.000, 300, 300, CRYSTAL STRUCTURES OF SARS CORONAVIRUS MAIN PEPTIDASE INHIBITED BY AN AZA-PEPTIDE EPOXIDE IN SPACE GROUP P212121
75, d3sndB_, 0.9805, 0.97, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC- ESTLQ-H (COCRYSTALLIZATION)
76, d2alvA1, 0.9805, 0.80, 1.000, 300, 300, X-RAY STRUCTURAL ANALYSIS OF SARS CORONAVIRUS 3CL PROTEINASE IN COMPLEX WITH DESIGNED ANTI-VIRAL INHIBITORS
77, d3m3vA_, 0.9800, 1.04, 0.990, 306, 302, SARS-COV MAIN PROTEASE TRIPLE MUTANT STI/A WITH TWO N-TERMINAL ADDITIONAL RESIDUE (GLY-SER)
78, d3avzA_, 0.9792, 0.82, 0.997, 300, 300, STRUCTURE OF SARS 3CL PROTEASE WITH PEPTIDIC ALDEHYDE INHIBITOR CONTAINING CYCLOHEXYL SIDE CHAIN
79, d2q6gA_, 0.9787, 1.00, 0.997, 305, 302, CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE H41A MUTANT IN COMPLEX WITH AN N-TERMINAL SUBSTRATE
80, d2ducA_, 0.9777, 1.07, 1.000, 306, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE(3CLPRO)
81, d2bx3A_, 0.9776, 0.85, 1.000, 300, 300, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (P43212)
82, d1uk2B_, 0.9776, 1.03, 1.000, 302, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) AT PH8.0
83, d2qc2A1, 0.9774, 1.04, 0.997, 304, 302, CRYSTAL STRUCTURE OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) 3C-LIKE PROTEASE ASN214ALA MUTANT
84, d2bx4A_, 0.9769, 0.65, 1.000, 298, 298, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (P21212)
85, d1uk3B_, 0.9768, 1.04, 1.000, 302, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) AT PH7.6
86, d1uk4A_, 0.9765, 0.91, 1.000, 301, 300, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) COMPLEXED WITH AN INHIBITOR
87, d3f9hB_, 0.9762, 1.09, 0.997, 300, 300, CRYSTAL STRUCTURE OF THE F140A MUTANT OF SARS-CORONOVIRUS 3C-LIKE PROTEASE AT PH 7.6
88, d3atwA_, 0.9760, 0.89, 0.997, 300, 300, STRUCTURE-BASED DESIGN SYNTHESIS EVALUATION OF PEPTIDE-MIMETIC SARS 3CL PROTEASE INHIBITORS
89, d5c5oA_, 0.9759, 0.89, 0.997, 300, 300, STRUCTURE OF SARS-3CL PROTEASE COMPLEX WITH A PHENYL-BETA-ALANYL (S R)-N-DECALIN TYPE INHIBITOR
90, d4hi3B_, 0.9759, 0.97, 0.997, 301, 301, CRYSTAL STRUCTURE OF DIMERIC R298A MUTANT OF SARS CORONAVIRUS MAIN PROTEASE
91, d1wofA1, 0.9759, 1.14, 1.000, 305, 302, CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR N1
92, d3f9fA_, 0.9756, 0.91, 0.997, 299, 299, CRYSTAL STRUCTURE OF THE F140A MUTANT OF SARS-CORONOVIRUS 3C-LIKE PROTEASE AT PH 6.0
93, d3f9fB_, 0.9755, 0.89, 0.997, 299, 299, CRYSTAL STRUCTURE OF THE F140A MUTANT OF SARS-CORONOVIRUS 3C-LIKE PROTEASE AT PH 6.0
94, d2gtbA_, 0.9754, 0.84, 1.000, 299, 299, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PEPTIDASE (WITH AN ADDITIONAL ALA AT THE N-TERMINUS OF EACH PROTOMER) INHIBITED BY AN AZA-PEPTIDE EPOXIDE IN THE SPACE GROUP P43212
95, d1uj1A_, 0.9754, 0.94, 1.000, 301, 300, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO)
96, d2vj1A_, 0.9746, 0.97, 1.000, 300, 300, A STRUCTURAL VIEW OF THE INACTIVATION OF THE SARS- CORONAVIRUS MAIN PROTEINASE BY BENZOTRIAZOLE ESTERS
97, d2gt8A_, 0.9746, 0.73, 1.000, 298, 298, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PEPTIDASE (WITH AN ADDITIONAL ALA AT THE N-TERMINUS OF EACH PROTOMER) IN THE SPACE GROUP P43212
98, d2amqA_, 0.9746, 0.95, 1.000, 303, 300, CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N3
99, d2amdA1, 0.9745, 1.17, 1.000, 305, 302, CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N9
100, d5b6oB_, 0.9744, 1.02, 0.997, 301, 301, CRYSTAL STRUCTURE OF MS8104
101, d2cggA_, 0.9744, 0.97, 1.000, 300, 300,  
102, d3f9hA_, 0.9743, 0.94, 0.997, 299, 299, CRYSTAL STRUCTURE OF THE F140A MUTANT OF SARS-CORONOVIRUS 3C-LIKE PROTEASE AT PH 7.6
103, d1uk2A_, 0.9743, 1.13, 1.000, 302, 302, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) AT PH8.0
104, d2yy4B_, 0.9739, 1.03, 0.997, 301, 301,  
105, d1z1iA_, 0.9739, 1.04, 1.000, 301, 301, CRYSTAL STRUCTURE OF NATIVE SARS CLPRO
106, d1z1jB_, 0.9737, 1.10, 0.997, 306, 302, CRYSTAL STRUCTURE OF SARS 3CLPRO C145A MUTANT
107, d3f9gA_, 0.9736, 0.66, 0.993, 297, 297, CRYSTAL STRUCTURE OF THE F140A MUTANT OF SARS-CORONOVIRUS 3C-LIKE PROTEASE AT PH 6.5
108, d3d62A_, 0.9723, 0.79, 0.983, 299, 298, DEVELOPMENT OF BROAD-SPECTRUM HALOMETHYL KETONE INHIBITORS AGAINST CORONAVIRUS MAIN PROTEASE 3CLPRO
109, d2op9B_, 0.9708, 0.98, 1.000, 299, 299, SUBSTRATE SPECIFICITY PROFILING AND IDENTIFICATION OF A NEW CLASS OF INHIBITOR FOR THE MAJOR PROTEASE OF THE SARS CORONAVIRUS
110, d2d2dA_, 0.9689, 1.06, 1.000, 301, 300, CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR I2
111, d1wnqA_, 0.9689, 1.06, 1.000, 301, 300,  
112, d1uk3A_, 0.9687, 1.08, 1.000, 301, 300, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) AT PH7.6
113, d1q2wA_, 0.9685, 0.67, 1.000, 295, 295, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS MAIN PROTEASE
114, d3f9gB_, 0.9682, 0.60, 0.993, 295, 295, CRYSTAL STRUCTURE OF THE F140A MUTANT OF SARS-CORONOVIRUS 3C-LIKE PROTEASE AT PH 6.5
115, d2gt7A_, 0.9665, 0.91, 1.000, 300, 297, CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PEPTIDASE AT PH 6.0 IN THE SPACE GROUP P21
116, d2z9lA_, 0.9660, 0.92, 1.000, 300, 297, COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH JMF1586
117, d1z1jA_, 0.9642, 1.27, 0.983, 306, 301, CRYSTAL STRUCTURE OF SARS 3CLPRO C145A MUTANT
118, d5b6oA_, 0.9625, 1.37, 0.997, 310, 302, CRYSTAL STRUCTURE OF MS8104
119, d2yy4A_, 0.9620, 1.38, 0.997, 310, 302,  
120, d1q2wB1, 0.9573, 1.38, 0.997, 310, 302, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS MAIN PROTEASE
121, d4twwB_, 0.9564, 1.02, 0.997, 295, 295, STRUCTURE OF SARS-3CL PROTEASE COMPLEX WITH A BROMOBENZOYL (SR)-N- DECALIN TYPE INHIBITOR
122, d3fzdA_, 0.9553, 1.44, 0.997, 306, 302, MUTATION OF ASN28 DISRUPTS THE ENZYMATIC ACTIVITY AND DIMERIZATION OF SARS 3CLPRO
123, d3atwB_, 0.9529, 1.12, 0.997, 296, 296, STRUCTURE-BASED DESIGN SYNTHESIS EVALUATION OF PEPTIDE-MIMETIC SARS 3CL PROTEASE INHIBITORS
124, d5c5oB_, 0.9517, 1.37, 0.997, 300, 300, STRUCTURE OF SARS-3CL PROTEASE COMPLEX WITH A PHENYL-BETA-ALANYL (S R)-N-DECALIN TYPE INHIBITOR
125, d4yoiB_, 0.9499, 1.39, 0.997, 300, 300, STRUCTURE OF HKU4 3CLPRO BOUND TO NON-COVALENT INHIBITOR 1A
126, d4yluA_, 0.9478, 1.49, 0.512, 306, 299, X-RAY STRUCTURE OF MERS-COV NSP5 PROTEASE BOUND WITH A NON-COVALENT INHIBITOR
127, d4yogB_, 0.9477, 1.49, 0.518, 304, 299, HKU4-3CLPRO BOUND TO NON-COVALENT INHIBITOR 3B
128, d2ynbB_, 0.9471, 1.48, 0.512, 306, 299, CRYSTAL STRUCTURE OF THE MAIN PROTEASE OF CORONAVIRUS HKU4 IN COMPLEX WITH A MICHAEL ACCEPTOR SG85
129, d4wmeC_, 0.9470, 1.49, 0.512, 302, 299, CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE MERS-COV 3CL PROTEASE (C148A) IN SPACEGROUP C2
130, d2zu2A_, 0.9468, 1.51, 0.515, 302, 299, COMPLEX STRUCTURE OF COV 229E 3CL PROTEASE WITH EPDTC
131, d4wmfA_, 0.9462, 1.40, 0.403, 300, 298, CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE MERS-COV 3CL PROTEASE (C148A) IN SPACEGROUP P212121
132, d4yojB_, 0.9461, 1.46, 0.513, 304, 298, HKU4 3CLPRO BOUND TO NON-COVALENT INHIBITOR 2A
133, d2ynaB_, 0.9456, 1.55, 0.512, 306, 299, CRYSTAL STRUCTURE OF THE MAIN PROTEASE OF CORONAVIRUS HKU4
134, d4wmeD_, 0.9449, 1.53, 0.512, 302, 299, CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE MERS-COV 3CL PROTEASE (C148A) IN SPACEGROUP C2
135, d4yluB_, 0.9446, 1.60, 0.515, 306, 299, X-RAY STRUCTURE OF MERS-COV NSP5 PROTEASE BOUND WITH A NON-COVALENT INHIBITOR
136, d4yluC_, 0.9444, 1.58, 0.518, 302, 299, X-RAY STRUCTURE OF MERS-COV NSP5 PROTEASE BOUND WITH A NON-COVALENT INHIBITOR
137, d4yogA_, 0.9441, 1.59, 0.518, 302, 299, HKU4-3CLPRO BOUND TO NON-COVALENT INHIBITOR 3B
138, d4xfqA_, 0.9428, 1.54, 0.512, 306, 299, CRYSTAL STRUCTURE BASIS FOR PEDV 3C LIKE PROTEASE
139, d4yo9B_, 0.9425, 1.45, 0.450, 298, 298, HKU4 3CLPRO UNBOUND STRUCTURE
140, d4yluD_, 0.9419, 1.52, 0.510, 301, 298, X-RAY STRUCTURE OF MERS-COV NSP5 PROTEASE BOUND WITH A NON-COVALENT INHIBITOR
141, d4wmeA_, 0.9419, 1.59, 0.518, 304, 299, CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE MERS-COV 3CL PROTEASE (C148A) IN SPACEGROUP C2
142, d4wmdB_, 0.9419, 1.63, 0.515, 306, 299, CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE MERS-COV 3CL PROTEASE (C148A) IN SPACEGROUP C2221
143, d4yoiA_, 0.9418, 1.59, 0.515, 304, 299, STRUCTURE OF HKU4 3CLPRO BOUND TO NON-COVALENT INHIBITOR 1A
144, d2ynbA_, 0.9417, 1.62, 0.512, 306, 299, CRYSTAL STRUCTURE OF THE MAIN PROTEASE OF CORONAVIRUS HKU4 IN COMPLEX WITH A MICHAEL ACCEPTOR SG85
145, d4yo9A_, 0.9416, 1.61, 0.512, 306, 299, HKU4 3CLPRO UNBOUND STRUCTURE
146, d4wmdC_, 0.9416, 1.61, 0.512, 306, 299, CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE MERS-COV 3CL PROTEASE (C148A) IN SPACEGROUP C2221
147, d4yojA_, 0.9415, 1.60, 0.515, 303, 299, HKU4 3CLPRO BOUND TO NON-COVALENT INHIBITOR 2A
148, d4wmfB_, 0.9414, 1.63, 0.512, 306, 299, CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE MERS-COV 3CL PROTEASE (C148A) IN SPACEGROUP P212121
149, d2zu2B_, 0.9406, 1.61, 0.515, 303, 299, COMPLEX STRUCTURE OF COV 229E 3CL PROTEASE WITH EPDTC
150, d3d23D_, 0.9401, 1.52, 0.403, 301, 298, MAIN PROTEASE OF HCOV-HKU1
151, d4hi3A_, 0.9385, 1.60, 0.482, 299, 299, CRYSTAL STRUCTURE OF DIMERIC R298A MUTANT OF SARS CORONAVIRUS MAIN PROTEASE
152, d3d23C_, 0.9372, 1.61, 0.997, 300, 300, MAIN PROTEASE OF HCOV-HKU1
153, d4wmeB_, 0.9363, 1.59, 0.480, 298, 298, CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE MERS-COV 3CL PROTEASE (C148A) IN SPACEGROUP C2
154, d5c3nA_, 0.9361, 1.71, 0.515, 304, 299, CRYSTAL STRUCTURE OF MERS CORONAVIRUS MAIN PROTEASE IN SPACEGROUP C2221
155, d2ynaA_, 0.9352, 1.61, 0.510, 301, 298, CRYSTAL STRUCTURE OF THE MAIN PROTEASE OF CORONAVIRUS HKU4
156, d5c3nB_, 0.9332, 1.71, 0.512, 306, 299, CRYSTAL STRUCTURE OF MERS CORONAVIRUS MAIN PROTEASE IN SPACEGROUP C2221
157, d5hyoB_, 0.9319, 1.62, 0.512, 300, 297, X-RAY STRUCTURE OF UNBOUND PORCINE EPIDEMIC DIARRHEA VIRUS 3CLPRO
158, d5hyoA_, 0.9294, 1.63, 0.453, 301, 298, X-RAY STRUCTURE OF UNBOUND PORCINE EPIDEMIC DIARRHEA VIRUS 3CLPRO
159, d3d23B1, 0.9290, 1.67, 0.453, 301, 298, MAIN PROTEASE OF HCOV-HKU1
160, d4xfqB_, 0.9289, 1.80, 0.482, 300, 299, CRYSTAL STRUCTURE BASIS FOR PEDV 3C LIKE PROTEASE
161, d3tloA_, 0.9279, 1.80, 0.482, 300, 299, CRYSTAL STRUCTURE OF HCOV-NL63 3C-LIKE PROTEASE
162, d3d23A1, 0.9197, 1.48, 0.456, 294, 294, MAIN PROTEASE OF HCOV-HKU1
163, d3tloB_, 0.9189, 1.72, 0.436, 302, 298, CRYSTAL STRUCTURE OF HCOV-NL63 3C-LIKE PROTEASE
164, d1p9sA_, 0.9157, 1.72, 0.436, 302, 298, CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS
165, d2ampB_, 0.9146, 1.80, 0.486, 297, 296, CRYSTAL STRUCTURE OF PORCINE TRANSMISSIBLE GASTROENTERITIS VIRUS MPRO IN COMPLEX WITH AN INHIBITOR N1
166, d1p9sB_, 0.9140, 1.87, 0.433, 302, 298, CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS
167, d4wmdA_, 0.9133, 1.39, 0.389, 290, 288, CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE MERS-COV 3CL PROTEASE (C148A) IN SPACEGROUP C2221
168, d2q6dB1, 0.9104, 1.94, 0.436, 299, 298, CRYSTAL STRUCTURE OF INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE
169, d2q6fB_, 0.9076, 1.42, 0.389, 289, 288, CRYSTAL STRUCTURE OF INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE IN COMPLEX WITH A MICHAEL ACCEPTOR INHIBITOR N3
170, d2q6fA_, 0.9036, 2.03, 0.500, 301, 298, CRYSTAL STRUCTURE OF INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE IN COMPLEX WITH A MICHAEL ACCEPTOR INHIBITOR N3
171, d2q6dA_, 0.9032, 1.98, 0.409, 306, 296, CRYSTAL STRUCTURE OF INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE
172, d2ampA_, 0.9026, 1.98, 0.409, 306, 296, CRYSTAL STRUCTURE OF PORCINE TRANSMISSIBLE GASTROENTERITIS VIRUS MPRO IN COMPLEX WITH AN INHIBITOR N1
173, d1lvoB_, 0.9021, 1.93, 0.408, 295, 294, STRUCTURE OF CORONAVIRUS MAIN PROTEINASE REVEALS COMBINATION OF A CHYMOTRYPSIN FOLD WITH AN EXTRA ALPHA- HELICAL DOMAIN
174, d1p9uC_, 0.9007, 1.94, 0.410, 294, 293, CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS
175, d1lvoC_, 0.8985, 2.09, 0.408, 296, 294, STRUCTURE OF CORONAVIRUS MAIN PROTEINASE REVEALS COMBINATION OF A CHYMOTRYPSIN FOLD WITH AN EXTRA ALPHA- HELICAL DOMAIN
176, d1p9uB_, 0.8981, 2.07, 0.440, 299, 298, CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS
177, d4f49B_, 0.8972, 2.08, 0.443, 300, 298, 2.25A RESOLUTION STRUCTURE OF TRANSMISSIBLE GASTROENTERITIS VIRUS PROTEASE CONTAINING A COVALENTLY BOUND DIPEPTIDYL INHIBITOR
178, d4f49D1, 0.8959, 2.08, 0.443, 300, 298, 2.25A RESOLUTION STRUCTURE OF TRANSMISSIBLE GASTROENTERITIS VIRUS PROTEASE CONTAINING A COVALENTLY BOUND DIPEPTIDYL INHIBITOR
179, d1lvoF_, 0.8951, 2.12, 0.443, 300, 298, STRUCTURE OF CORONAVIRUS MAIN PROTEINASE REVEALS COMBINATION OF A CHYMOTRYPSIN FOLD WITH AN EXTRA ALPHA- HELICAL DOMAIN
180, d4f49A1, 0.8910, 2.15, 0.443, 300, 298, 2.25A RESOLUTION STRUCTURE OF TRANSMISSIBLE GASTROENTERITIS VIRUS PROTEASE CONTAINING A COVALENTLY BOUND DIPEPTIDYL INHIBITOR
181, d4f49C1, 0.8906, 2.09, 0.444, 297, 297, 2.25A RESOLUTION STRUCTURE OF TRANSMISSIBLE GASTROENTERITIS VIRUS PROTEASE CONTAINING A COVALENTLY BOUND DIPEPTIDYL INHIBITOR
182, d1lvoD_, 0.8888, 2.12, 0.441, 298, 297, STRUCTURE OF CORONAVIRUS MAIN PROTEINASE REVEALS COMBINATION OF A CHYMOTRYPSIN FOLD WITH AN EXTRA ALPHA- HELICAL DOMAIN
183, d1p9uF_, 0.8868, 2.19, 0.443, 299, 298, CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS
184, d1p9uD_, 0.8863, 2.24, 0.433, 299, 298, CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS
185, d1lvoA_, 0.8773, 2.25, 0.433, 299, 298, STRUCTURE OF CORONAVIRUS MAIN PROTEINASE REVEALS COMBINATION OF A CHYMOTRYPSIN FOLD WITH AN EXTRA ALPHA- HELICAL DOMAIN
186, d1p9uA_, 0.8734, 2.25, 0.443, 301, 298, CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS
187, d1lvoE_, 0.8708, 2.30, 0.443, 300, 298, STRUCTURE OF CORONAVIRUS MAIN PROTEINASE REVEALS COMBINATION OF A CHYMOTRYPSIN FOLD WITH AN EXTRA ALPHA- HELICAL DOMAIN
188, d1p9uE_, 0.8697, 2.30, 0.440, 301, 298, CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS
189, d2qcyA_, 0.7182, 2.42, 0.440, 299, 298, CRYSTAL STRUCTURE OF A MONOMERIC FORM OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) 3C-LIKE PROTEASE MUTANT
190, d3m3tA1, 0.7159, 2.47, 0.440, 299, 298, SARS-COV MAIN PROTEASE MONOMERIC ARG298ALA MUTANT WITH N-TERMINAL ADDITIONAL RESIDUES (GLY-SER)
191, d3f9eA_, 0.7055, 2.50, 0.443, 299, 298, CRYSTAL STRUCTURE OF THE S139A MUTANT OF SARS-CORONOVIRUS 3C-LIKE PROTEASE
192, d2pwxA_, 0.6934, 2.52, 0.440, 299, 298, CRYSTAL STRUCTURE OF G11A MUTANT OF SARS-COV 3C-LIKE PROTEASE
193, p3iwmB1, 0.6617, 4.39, 0.787, 306, 296, THE OCTAMERIC SARS-COV MAIN PROTEASE
194, d2q6dC_, 0.6509, 4.42, 0.794, 305, 296, CRYSTAL STRUCTURE OF INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE
195, p3vb6A1, 0.6459, 4.42, 0.762, 297, 290, CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH C6Z
196, p3vb4A1, 0.6449, 4.30, 0.730, 289, 282, CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH B4Z
197, p3vb7A1, 0.6446, 0.82, 0.980, 204, 203, CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH M4Z
198, p3vb5A1, 0.6438, 4.66, 0.392, 302, 268, CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH C4Z
199, p3vb7B1, 0.6435, 0.71, 1.000, 197, 197, CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH M4Z
200, p5n19A1, 0.6432, 0.52, 0.980, 197, 196, STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE IN COMPLEX WITH THE ALPHA- KETOAMIDE (S)-N-BENZYL-3-((S)-2-CINNAMAMIDO-3-PHENYLPROPANAMIDO)-2- OXO-4-((S)-2-OXOPYRROLIDIN-3-YL)BUTANAMIDE
201, p3vb6B1, 0.6428, 0.78, 1.000, 197, 197, CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH C6Z
202, p3vb5B1, 0.6426, 0.59, 0.980, 197, 196, CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH C4Z
203, p3vb4B1, 0.6426, 0.83, 1.000, 197, 197, CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH B4Z
204, p5wkjA1, 0.6354, 0.84, 1.000, 197, 197, 2.05 A RESOLUTION STRUCTURE OF MERS 3CL PROTEASE IN COMPLEX WITH INHIBITOR GC376
205, p4rspA1, 0.6348, 0.64, 0.980, 197, 196, X-RAY STRUCTURE OF MERS-COV NSP5 PROTEASE BOUND WITH A DESIGNED INHIBITOR
206, p4zuhA1, 0.6323, 0.65, 0.980, 197, 196, COMPLEX STRUCTURE OF PEDV 3CLPRO MUTANT (C144A) WITH A PEPTIDE SUBSTRATE.
207, p5nh0B1, 0.6316, 0.87, 1.000, 197, 197, STRUCTURE OF HUMAN CORONAVIRUS NL63 MAIN PROTEASE IN COMPLEX WITH THE ALPHA-KETOAMIDE TERT-BUTYL ((S)-4-(BENZYLAMINO)-3;4-DIOXO-1-((S)-2- OXOPYRROLIDIN-3-YL)B- UTAN-2-YL)CARBAMATE (TERT-BUTYL -GLNLACTAM-CO- CO-NH-BENZYL) 
208, p5nh0A1, 0.6315, 1.12, 0.566, 199, 196, STRUCTURE OF HUMAN CORONAVIRUS NL63 MAIN PROTEASE IN COMPLEX WITH THE ALPHA-KETOAMIDE TERT-BUTYL ((S)-4-(BENZYLAMINO)-3;4-DIOXO-1-((S)-2- OXOPYRROLIDIN-3-YL)B- UTAN-2-YL)CARBAMATE (TERT-BUTYL -GLNLACTAM-CO- CO-NH-BENZYL) 
209, p5nh0C1, 0.6309, 1.01, 0.571, 199, 196, STRUCTURE OF HUMAN CORONAVIRUS NL63 MAIN PROTEASE IN COMPLEX WITH THE ALPHA-KETOAMIDE TERT-BUTYL ((S)-4-(BENZYLAMINO)-3;4-DIOXO-1-((S)-2- OXOPYRROLIDIN-3-YL)B- UTAN-2-YL)CARBAMATE (TERT-BUTYL -GLNLACTAM-CO- CO-NH-BENZYL) 
210, p5wkmA1, 0.6297, 0.98, 0.462, 196, 195, 2.25 A RESOLUTION STRUCTURE OF MERS 3CL PROTEASE IN COMPLEX WITH PIPERIDINE-BASED PEPTIDOMIMETIC INHIBITOR 21
211, p4zroA1, 0.6256, 1.17, 0.464, 197, 196, 2.1 A X-RAY STRUCTURE OF FIPV-3CLPRO BOUND TO COVALENT INHIBITOR
212, p5gwzA1, 0.6250, 1.02, 0.446, 197, 195, THE STRUCTURE OF PORCINE EPIDEMIC DIARRHEA VIRUS MAIN PROTEASE IN COMPLEX WITH AN INHIBITOR
213, p5gwzB1, 0.6244, 1.04, 0.446, 197, 195, THE STRUCTURE OF PORCINE EPIDEMIC DIARRHEA VIRUS MAIN PROTEASE IN COMPLEX WITH AN INHIBITOR
214, p4zroC1, 0.6244, 1.24, 0.585, 197, 195, 2.1 A X-RAY STRUCTURE OF FIPV-3CLPRO BOUND TO COVALENT INHIBITOR
215, p4zuhB1, 0.6229, 1.36, 0.469, 196, 196, COMPLEX STRUCTURE OF PEDV 3CLPRO MUTANT (C144A) WITH A PEPTIDE SUBSTRATE.
216, p5gwyA1, 0.6216, 1.16, 0.459, 195, 194, STRUCTURE OF MAIN PROTEASE FROM HUMAN CORONAVIRUS NL63: INSIGHTS FOR WIDE SPECTRUM ANTI-CORONAVIRUS DRUG DESIGN
217, p4zroB1, 0.6195, 1.18, 0.459, 195, 194, 2.1 A X-RAY STRUCTURE OF FIPV-3CLPRO BOUND TO COVALENT INHIBITOR
218, p4zroD1, 0.6192, 1.26, 0.456, 196, 195, 2.1 A X-RAY STRUCTURE OF FIPV-3CLPRO BOUND TO COVALENT INHIBITOR
219, p5wklA2, 0.6088, 0.99, 0.490, 192, 192, 1.85 A RESOLUTION STRUCTURE OF MERS 3CL PROTEASE IN COMPLEX WITH PIPERIDINE-BASED PEPTIDOMIMETIC INHIBITOR 17
220, p5wkkA2, 0.6040, 1.13, 0.440, 195, 193, 1.55 A RESOLUTION STRUCTURE OF MERS 3CL PROTEASE IN COMPLEX WITH INHIBITOR GC813
221, p5gwyB2, 0.5981, 1.36, 0.454, 196, 194, STRUCTURE OF MAIN PROTEASE FROM HUMAN CORONAVIRUS NL63: INSIGHTS FOR WIDE SPECTRUM ANTI-CORONAVIRUS DRUG DESIGN
222, d4wmfC_, 0.5785, 1.48, 0.456, 196, 195, CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE MERS-COV 3CL PROTEASE (C148A) IN SPACEGROUP P212121
